3-(3',4'-dimethoxyphenyl)-5-phenyl-1H-pyrazole | 1196986-16-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-(3',4'-dimethoxyphenyl)-5-phenyl-1H-pyrazole
• 英文别名: 3-(3,4-dimethoxyphenyl)-5-phenyl-1H-pyrazole
• CAS: 1196986-16-9
• 化学式: C₁₇H₁₆N₂O₂
• 分子量: 280.326
• InChiKey: ZKTPOZIRILPSSL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  47.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  1-(3,4-dimethoxyphenyl)-3-phenylprop-2-yn-1-one 在 一水合肼 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 1.0h， 以456 mg的产率得到3-(3',4'-dimethoxyphenyl)-5-phenyl-1H-pyrazole
  参考文献：
  名称：

  由末端炔烃，醛，肼和羟胺制备3,5-二取代吡唑和异恶唑

  摘要：

  末端炔与正丁基锂的反应，然后与醛的反应，再用分子碘处理，然后肼或羟胺以高收率提供相应的3,5-二取代的吡唑或异恶唑，其高区域选择性通过形成炔丙基仲醇盐和α-炔基酮。本反应是从末端炔烃，醛，分子碘和肼一锅制备3，5-二取代吡唑，和从末端炔烃，醛，分子碘和羟胺一锅制备3，5-二取代异恶唑。

  DOI：

  10.1021/jo4027116

文献信息

• [EN] NOVEL SUBSTITUTED PYRAZOLES, 1,2,4-OXADIAZOLES, AND 1,3,4-OXADIAZOLES<br/>[FR] NOUVEAUX PYRAZOLES SUBSTITUÉS, 1,2,4-OXADIAZOLES, ET 1,3,4-OXADIAZOLES
  申请人：MERCK & CO INC

  公开号：WO2009146343A1

  公开（公告）日：2009-12-03

  The present invention relates to novel amyloid binding compounds and methods for measuring effects of the compounds, by measuring changes of amyloid plaque level in living patients. More specifically, the present invention relates to a method of using the compounds of this invention as tracers in positron emission tomography (PET) imaging to study amyloid deposits in brain in vivo to allow diagnosis of Alzheimer's disease. Thus, the present invention relates to use of the novel amyloid binding compounds as a diagnostic. The invention further relates to a method of measuring clinical efficacy of Alzheimer's disease therapeutic agents. Specifically, the present invention relates to novel aryl or heteroaryl substituted pyrazole derivatives, compositions, and therapeutic uses and processes for making such compounds.

  本发明涉及新型淀粉样蛋白结合化合物和测量这些化合物效果的方法，通过测量活体患者淀粉样斑块水平的变化。更具体地说，本发明涉及一种利用本发明化合物作为示踪剂在正电子发射断层扫描（PET）成像中研究活体大脑中淀粉样沉积以进行阿尔茨海默病诊断的方法。因此，本发明涉及将新型淀粉样蛋白结合化合物用作诊断的用途。该发明还涉及一种测量阿尔茨海默病治疗药物临床疗效的方法。具体而言，本发明涉及新型芳基或杂环芳基取代的吡唑衍生物、组成物和制备此类化合物的治疗用途和方法。
• Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles
  申请人：Barrow James C.

  公开号：US20110081297A1

  公开（公告）日：2011-04-07

  The present invention relates to novel amyloid binding compounds and methods for measuring effects of the compounds, by measuring changes of amyloid plaque level in living patients. More specifically, the present invention relates to a method of using the compounds of this invention as tracers in positron emission tomography (PET) imaging to study amyloid deposits in brain in vivo to allow diagnosis of Alzheimer's disease. Thus, the present invention relates to use of the novel amyloid binding compounds as a diagnostic. The invention further relates to a method of measuring clinical efficacy of Alzheimer's disease therapeutic agents. Specifically, the present invention relates to novel aryl or heteroaryl substituted pyrazole derivatives, compositions, and therapeutic uses and processes for making such compounds.

  本发明涉及新型淀粉样蛋白结合化合物及测量这些化合物效果的方法，通过测量活体患者淀粉样斑块水平的变化来实现。更具体地说，本发明涉及使用本发明化合物作为追踪剂在正电子发射断层扫描（PET）成像中研究体内脑部淀粉样沉积，以诊断阿尔茨海默病。因此，本发明涉及将新型淀粉样蛋白结合化合物用作诊断工具。本发明还涉及测量阿尔茨海默病治疗药物的临床疗效的方法。具体而言，本发明涉及新型芳基或杂环芳基取代的吡唑衍生物、组成物以及制备这些化合物的治疗用途和过程。